CRWRF Stock Analysis
CR
Uncovered
Craneware PLC is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
1.047
Dividend yield
1.87 %
Shares outstanding
35.194 B
Craneware Plc engages in the provision of software and support services for the healthcare industry. The firm's Value Cycle Solutions has five product families, which include Patient Engagement, Charge Capture and Pricing, Claims Analytics, Revenue Recovery and Retention, and Cost and Margin Analytics. The Company’s solutions include Chargemaster Toolkit, Trisus Supply, Physician Revenue Toolkit, Reference Plus, Integration for Chargemaster Management, Pharmacy ChargeLink, Trisus Pricing Analyzer, Online Reference Toolkit, Trisus Supplies Assistant, InSight Medical Necessity, Trisus Claims Informatics, InSight Audit, Trisus Healthcare Intelligence, Trisus Pricing Transparency, InSight Denials, Appeals Service, and Customer Success Management and Consulting Services. The company has approximately 2,000 United States hospitals and health systems and almost 10,000 clinics and affiliated retail pharmacies.